References
- Centres for Disease Control and Prevention and the U. S.P.H.S. Working Group. Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-II). Ann Intern Med 1993; 118(6): 448–54
- Martin JD, Mathias RG. Hepatitis B Surveillance in first Nations Alcohol and Drug Treatment Centres in British Columbia, Canada. Proceedings of the 10th International Congress on Circumpolar Health. Anchorage, Alaska 1998: 280–84
- Murphy EL, Glynn SA, Fridey J et al. Increased prevalence of infectious diseases and other adverse outcomes in human T-lymphotropic virus types I-and II-infected blood donors. J Infect Dis 1997; 176: 1468–75
- Murphy EL, Glynn SA, Fridey J, et al. Increased incidence of infectious diseases during prospective follow-up of human T-lymphotropic virus type-II and I-infected blood donors. Arch Intern Med 1999; 159(13):1485–1491
- Murphy EL, Watanabe K, Nass CC, Ownby H, Williams A, Nemo G. Evidence among blood donors for a 30-year-old epidemic of human T-lymphotropic virus type II in the United States. J Infect Dis 1999; 180; 1777–83
- Oger JJF, Werker DH, Foti DJ, Dekaban GA. HTLV-I associated myelopathy: an endemic disease of Canadian aboriginals of the Northwest Pacific coast? Can J Neurol Sci 1993; 20: 302–306
- Peters AA, Coulthart MB, Oger JJF et al. HTLV type I/II in British Columbia Amerindians: a seroprevalence study and sequence characterization of an HTLV type Ha isolate. AIDS Res Hum Retroviruses 2000; 16(9):883–892
- Picard FJ, Coulthart MB, Oger JJF et al. Human T-lymphotropic virus type I in coastal natives of British Columbia: phylogenetic affinities and possible origins. J Virol 1995; 69(11): 7248–56
- Salemi M, Lewis M, Egan JF, Hall WW, Desmyter J, Vandamme AM. Different population dynamics of human T-cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes. Proc Natl Acad Sci USA 1999; 96(23):13253–13258
- Salemi M, Vandamme AM, Desmyter J, Casoli C, Bertazzoni U. The origin and evolution of human T-cell lymphotropic virus type II (HTLV-II) and the relationship with its replication strategy. Gene 1999; 234:11–21
- Schwebke J, Calsyn D, Shriver K, et al. Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users. J Infect Dis 1994; 169: 962–7
- Tajima K. Worldwide distribution of HTLV. Jpn J Cancer Res 1998; 89(1): inside front cover
- Voevodin A, Gessain A. Common origin of human T-lymphotropic virus type I from Iran, Kuwait, Israel, and La Reunion Island. J Med Virol 1997; 52(1):77–82.